• OPEN AN ACCOUNT
Indian Indices
Sensex
78,079.96 113.61
( 0.15%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
68,341.16 817.10
(1.21%)
Nikkei 225
10,757.72 -75.43
(-0.70%)
Forex
USD-INR
95.38 0.10
(0.10%)
EUR-INR
110.06 0.02
(0.01%)
GBP-INR
128.81 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
40.3
995.92
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

pakka ltd
Godrej Properties gains on acquiring land parcel in Chennai with Rs 500 crore revenue potential
Jun 30,2026

The proposed development on this land will comprise primarily plotted residential units and is expected to offer a developable potential of nearly 1.2 million square feet, with an estimated revenue potential of Rs 500 crore.

The site is well connected via OMR, providing access to key employment hubs across the Siruseri–Kelambakkam corridor, including SIPCOT as well as emerging nodes such as Vandalur, Guduvanchery, and the wider Mahabalipuram region.

Gaurav Pandey, MD & CEO, Godrej Properties, said: “South Chennai is seeing a clear evolution in residential demand, with homebuyers increasingly gravitating towards well planned, future-ready communities that offer quality of living and long-term value.

This belt has emerged as one of the most promising residential micro markets in the region, supported by improving infrastructure and growing end user interest.'

Godrej Properties is a leading national real estate developer. It is a real estate arm of the Godrej Group. The company currently operates in various cities and focuses on residential, commercial, and township development.

The company’s consolidated net profit jumped 70.13% to Rs 649.88 crore on a 41.98% increase in total income to Rs 3,806.65 crore in Q4 FY26 over Q4 FY25.